Peptides, proteins, and the risks of cardiac arrythmias: A CDER study suggests that the human Thorough QT study is not needed for products comprised of naturally occurring amino acids

Peptides, proteins, and the risks of cardiac arrythmias: a CDER study suggests that the human Thorough QT study is not needed for products comprised of naturally occurring amino acids

Source: FDA Center for Drug Evaluation and Research - What's New - April 25, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news